GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (XTER:EVT) » Definitions » Days Payable

Evotec SE (XTER:EVT) Days Payable : 38.85 (As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Evotec SE Days Payable?

Evotec SE's average Accounts Payable for the three months ended in Mar. 2025 was €73.5 Mil. Evotec SE's Cost of Goods Sold for the three months ended in Mar. 2025 was €172.8 Mil. Hence, Evotec SE's Days Payable for the three months ended in Mar. 2025 was 38.85.

The historical rank and industry rank for Evotec SE's Days Payable or its related term are showing as below:

XTER:EVT' s Days Payable Range Over the Past 10 Years
Min: 35.93   Med: 42.13   Max: 69.7
Current: 43.22

During the past 13 years, Evotec SE's highest Days Payable was 69.70. The lowest was 35.93. And the median was 42.13.

XTER:EVT's Days Payable is ranked worse than
80.04% of 922 companies
in the Drug Manufacturers industry
Industry Median: 87.915 vs XTER:EVT: 43.22

Evotec SE's Days Payable declined from Mar. 2024 (61.23) to Mar. 2025 (38.85). It may suggest that Evotec SE accelerated paying its suppliers.

Evotec SE Days Payable Historical Data

The historical data trend for Evotec SE's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evotec SE Days Payable Chart

Evotec SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.93 45.05 53.69 69.70 58.89

Evotec SE Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.23 51.03 42.95 40.56 38.85

Competitive Comparison of Evotec SE's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evotec SE's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's Days Payable distribution charts can be found below:

* The bar in red indicates where Evotec SE's Days Payable falls into.


;
;

Evotec SE Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Evotec SE's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

Days Payable (A: Dec. 2024 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2023 ) + Accounts Payable (A: Dec. 2024 )) / count ) / Cost of Goods Sold (A: Dec. 2024 )*Days in Period
=( (134.319 + 85.792) / 2 ) / 682.086*365
=110.0555 / 682.086*365
=58.89

Evotec SE's Days Payable for the quarter that ended in Mar. 2025 is calculated as:

Days Payable (Q: Mar. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2024 ) + Accounts Payable (Q: Mar. 2025 )) / count ) / Cost of Goods Sold (Q: Mar. 2025 )*Days in Period
=( (85.792 + 61.299) / 2 ) / 172.752*365 / 4
=73.5455 / 172.752*365 / 4
=38.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evotec SE Days Payable Related Terms

Thank you for viewing the detailed overview of Evotec SE's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Evotec SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (XTER:EVT) » Definitions » Days Payable
Comparable Companies
FRA:DMP FRA:APPH XTER:B8FK ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA SHSE:688506 TSE:4507 BOM:500087 SZSE:000538 NSE:TORNTPHARM UTHR BOM:500124
Traded in Other Exchanges
EVO:USA 1EVT:Italy EVTd:UK 0IRF:UK EVT:Bulgaria EVT:Austria
Address
Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419
Website
https://www.evotec.com
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Executives
Dr. Christian Wojczewski Board of Directors
Aurélie Dalbiez Board of Directors
Prof. Dr. Iris Löw-friedrich Supervisory Board
Dr. Craig Johnstone Board of Directors
Dr. Cord Dohrmann Board of Directors
Dr. Werner Lanthaler Board of Directors